France Ends Regime 42 in 2026: Fiscal Reps Now a Must for Non-EU Firms

France Ends Regime 42: A Guide to QMS and Regulatory Impacts for Medical Device Manufacturers The planned 2026 termination of France's "Regime 42" VAT simplification procedure represents a significant operational shift for non-EU medical device manufacturers. This change mandates the appointment of a VAT Fiscal Representative for businesses importing goods into France and subsequently supplying them to other EU member states. While the immediate focus is often on tax compliance and financial logistics, the deeper, and often overlooked, impacts on a manufacturer's Quality Management System (QMS), regulatory compliance under the EU MDR, and supply chain integrity are far more critical for ensuring uninterrupted market access. This change introduces a new entity into the supply chain that must be managed with the same rigor as any other critical supplier. For medical device manufacturers, this is not merely a financial or administrative update; it is a regulatory event that requires proactive adjustments to QMS procedures, contractual agreements, and vigilance systems. Failing to integrate this new fiscal partner into the existing regulatory framework can create compliance gaps, leading to potential audit non-conformities, shipment delays, and risks to device traceability and post-market surveillance. ### Key Points * **QMS Integration is Mandatory:** The appointed Fiscal Representative must be treated as a critical supplier and fully integrated into the manufacturer's QMS (compliant with ISO 13485 and EU MDR). This includes qualification, evaluation, monitoring, and having a formal quality agreement in place. * **Redefining Economic Operator Roles:** The change necessitates a clear, documented delineation of responsibilities between the manufacturer, EU Authorized Representative (EUAR), the newly appointed Fiscal Representative, and the entity acting as the Importer under EU MDR Article 13. * **Contractual Amendments are Essential:** All relevant agreements with EU economic partners (EUAR, importers, distributors) must be reviewed and amended. The contract with the Fiscal Representative must explicitly define their role, responsibilities, and communication pathways for regulatory matters, especially vigilance reporting. * **Vigilance and PMS System Updates:** The Fiscal Representative becomes a new potential point of contact for device-related issues (e.g., customs holds, damaged goods). Procedures for post-market surveillance (PMS) and vigilance must be updated to ensure any information received by them is immediately routed to the manufacturer's regulatory team. * **Traceability and Documentation:** QMS procedures must be updated to ensure that the activities of the Fiscal Representative are documented and that device traceability (including UDI) is maintained throughout the customs and importation process. This documentation is critical for demonstrating a controlled supply chain during Notified Body and Competent Authority audits. ## Understanding the Shift: Fiscal Representative vs. Importer vs. EUAR Before updating a QMS, it is crucial to understand the distinct roles of the entities involved in the EU supply chain. The end of Regime 42 forces manufacturers to formalize these roles with greater clarity. * **VAT Fiscal Representative:** A local French entity that is jointly and severally liable for the non-EU manufacturer's VAT obligations in France. Their primary role is financial and administrative: managing VAT registration, filing returns, and paying VAT. However, they are often involved in the customs clearance process, placing them physically in the supply chain. * **EU Authorized Representative (EUAR):** A regulatory liaison mandated by the EU MDR. The EUAR acts on behalf of the non-EU manufacturer for specific regulatory tasks, such as interfacing with Competent Authorities, holding a copy of the Technical Documentation, and being named on the device labeling. Their role is purely regulatory, not commercial or fiscal. * **Importer (as defined by EU MDR Article 13):** The entity that first places a device from a third country on the Union market. The Importer has significant regulatory responsibilities, including verifying the device's CE mark and declaration of conformity, ensuring their name and address are on the device/packaging, and maintaining a register of complaints. The critical challenge is that the Fiscal Representative may or may not also be the legal Importer. These roles can be fulfilled by different entities, and the manufacturer’s QMS and contracts must precisely reflect the chosen operational model. ## Integrating the Fiscal Representative into an ISO 13485 QMS Treating the Fiscal Representative as a mere administrative service provider is a common mistake that can lead to major non-conformities. Under ISO 13485, any outsourced process that affects the QMS must be controlled. The appointment of a Fiscal Representative directly impacts distribution and traceability, which are core QMS processes. ### Step 1: Supplier Qualification and Onboarding The Fiscal Representative must be qualified as a critical supplier. The process should be documented and include: * **Initial Evaluation:** Assess the provider's expertise. Do they have experience with medical devices? Do they understand the regulatory sensitivity of the products they will be handling for customs purposes? * **Quality System Assessment:** While they may not be ISO 13485 certified, they must demonstrate they have controlled procedures for record-keeping, communication, and handling of non-conformances (e.g., what to do if a shipment is damaged upon arrival). * **Formal Quality Agreement:** This is a non-negotiable document. It must be established alongside the service contract and define quality and regulatory-related responsibilities, including communication protocols for complaints, vigilance events, and feedback. ### Step 2: Updating QMS Procedures and Work Instructions Several key SOPs within the manufacturer's QMS will require revision: 1. **Supplier Management (e.g., Section 7.4 of ISO 13485):** Add "VAT Fiscal Representative" to the list of critical supplier types. Define the specific criteria for their selection, evaluation, and re-evaluation. 2. **Distribution and Logistics Controls:** Update procedures to reflect the new workflow for shipments entering the EU via France. This must detail the flow of information and documentation between the manufacturer, freight forwarder, Fiscal Representative, and the final consignee. 3. **Traceability:** The system must capture the link between a batch/serial number (and its UDI) and the specific import declaration managed by the Fiscal Representative. This ensures end-to-end traceability that can stand up to auditor scrutiny. 4. **Complaint Handling and Vigilance:** This is one of the most critical updates. The procedure must explicitly state that the Fiscal Representative is a potential source of complaints or vigilance triggers. It should include: * A work instruction for the Fiscal Representative on how to identify and immediately report any device-related issue (e.g., damaged packaging, temperature excursion, incorrect labeling noticed during customs inspection). * Clear contact information for the manufacturer’s person responsible for vigilance. * Defined timelines for reporting, consistent with MDR vigilance requirements. ## Contractual Amendments and Delineating Responsibilities Clear contracts are the foundation of a compliant supply chain. The introduction of a Fiscal Representative requires a thorough review of all existing agreements. ### Scenario 1: Fiscal Representative is a Separate Entity from the Importer This is a common setup where a specialized firm handles VAT and a separate logistics partner or commercial entity acts as the MDR Importer. * **What an Auditor Will Scrutinize:** * Is there a clear contract with the Importer defining their Article 13 responsibilities? * Is there a separate contract and quality agreement with the Fiscal Representative defining their limited role in customs and VAT? * How do these two entities coordinate to ensure smooth customs clearance without compromising the Importer's ability to verify the shipment? * **Critical Contractual Clauses to Add:** * **Agreement with Fiscal Rep:** Explicitly state they are NOT the regulatory Importer and must not undertake any Article 13 responsibilities. Define the exact communication protocol for handing over customs-cleared goods to the designated Importer. * **Agreement with Importer:** Clarify their obligation to perform verification checks and how they will gain access to the goods post-customs clearance by the Fiscal Representative. ### Scenario 2: Fiscal Representative Also Acts as the MDR Importer Some larger providers may offer to act as both the Fiscal Representative and the MDR Importer. * **What an Auditor Will Scrutinize:** * Does this entity fully understand and have the resources to meet the extensive obligations of an MDR Importer (e.g., QMS, complaint handling, cooperation in field actions)? * Is their name and address correctly added to the device labeling or packaging as required? * Is the quality agreement robust enough to cover both fiscal duties and the full scope of MDR Article 13 regulatory responsibilities? * **Critical Contractual Clauses to Add:** * The service agreement must have a comprehensive section or appendix detailing every Importer obligation under MDR Article 13 and how the provider will fulfill it. This includes record-keeping, complaint forwarding, and cooperation with the manufacturer and authorities. ## Strategic Considerations and Notified Body Engagement The end of Regime 42 should be viewed as a strategic opportunity to strengthen and clarify the EU supply chain. * **Provider Selection:** Do not select a Fiscal Representative based on cost alone. Prioritize providers with demonstrable experience in the medical device or life sciences sector. They are more likely to understand the importance of QMS integration, traceability, and vigilance reporting. * **Preparing for Audits:** Notified Bodies and Competent Authorities will view the Fiscal Representative as a key part of the manufacturer's outsourced distribution process. During an audit, be prepared to present: * The supplier qualification file for the Fiscal Representative. * The signed quality agreement. * Updated SOPs for distribution, traceability, and vigilance. * Records demonstrating communication and control, such as meeting minutes or performance reviews. * **Proactive Communication:** While not always required, it may be prudent to proactively inform your Notified Body of significant changes to your EU importation and distribution model, demonstrating that you have assessed the risks and updated your QMS accordingly. ## Key EU Regulatory References When updating procedures, manufacturers should refer to the primary sources to ensure compliance. - **EU Medical Device Regulation (EU) 2017/745 (MDR):** Specifically Article 13 (General obligations of importers) and Article 11 (Authorised representative). - **ISO 13485:2016 - Medical devices — Quality management systems:** Specifically Section 4.1 (General requirements) on controlling outsourced processes and Section 7.4 (Purchasing) on supplier controls. - **MDCG Guidance Documents:** Refer to guidance related to economic operators, importers, and traceability (e.g., MDCG 2021-27 on Q&A regarding Articles 13 & 14). - **Official guidance from the French Directorate General of Public Finances (DGFiP)** on the new requirements for VAT fiscal representation. ## Finding and Comparing VAT Fiscal Representative Providers Choosing the right partner is critical to ensuring a seamless transition and maintaining regulatory compliance. When evaluating providers, manufacturers should look for a partner who understands the unique demands of the medical device industry. Key criteria include experience with medtech products, a strong understanding of EU MDR obligations (especially the role of the Importer), and a willingness to operate under a formal quality agreement. It is essential to compare several qualified providers to find the best fit for your company’s specific needs and product portfolio. A thorough evaluation process will help ensure your chosen representative can function as a reliable partner in your compliant supply chain. To find qualified vetted providers [click here](https://cruxi.ai/regulatory-directories/vat_fiscal_rep) and request quotes for free. *** *This article is for general educational purposes only and is not legal, medical, or regulatory advice. For device-specific questions, sponsors should consult qualified experts and consider engaging FDA via the Q-Submission program.* --- *This answer was AI-assisted and reviewed for accuracy by Lo H. Khamis.*